Focusing on prevention approaches in COPD (including inhaled and non-inhaled advanced therapies, use of eosinophil biomarkers etc), approaches to distinguishing viral from bacterial infections (with associated implications for antibiotic stewardship) and an update on current understanding and approaches to managing long COVID syndromes.
Learning objectives:
Dr Aran Singanayagam Background
Dr Aran Singanayagam completed his medical training at the University of Edinburgh in 2005 achieving distinction in his final examinations alongside a first-class intercalated BSc in physiology. He trained as a respiratory doctor within north-west London, primarily at St Mary’s, Royal Brompton and Harefield hospitals.
IRON MAN TRIAL OBJECTIVES
The Ironman trial examines the connection between patients with heart failure, reduced left ventricular ejection fraction, iron deficiency, intravenous ferric carboxymaltose administration and whether it improves quality of life and exercise capacity in the short term and reduces hospital admissions for heart failure up to one year. This study aimed to evaluate the longer-term effects of intravenous ferric derisomaltose on cardiovascular events in patients with heart failure.
PROFESSOR PAUL KALRA BACKGROUND
Todays RBH grand round is presented by Professor Paul Kalra. Professor Kalra started as a Consultant Cardiologist at Portsmouth Hospitals NHS Trust in April 2004. In 2019 he was appointed as Honorary Professor of Cardiology.
He is Chief Investigator for the BHF funded Ironman trial study evaluating the role of intravenous iron in patients with heart failure (IRONMAN – 75 UK centres), which has the potential to shape international guidelines and clinical practice.
Whilst he has a broad interest in all aspects of general adult cardiology, his sub-specialty interest is the assessment and management of patients with heart failure. He has championed local heart failure service development spanning primary, secondary and tertiary care. In addition, he co-developed the local complex device service, initiating local implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy device (CRT) implantation and follow up. Paul has extensive expertise in assessment of patients for and the implantation of pacemakers and other complex devices (CRT and ICD).
Paul has been on the British Society for Heart Failure Board since 2009 and was elected Chair 2017-2019 (now past chair). This is the national body providing expert advice, support and education to NHS organizations, professionals and patients (working closely with patient groups). During his role as Chair he was instrumental in getting heart failure recognised as a priority and incorporated into the NHS Long Term Plan published in 2019. He is currently helping to drive implementation of change, contributing to NHS England’s NHS Long Term Plan Heart Failure and Heart Valve Disease Expert Advisory Group. He has helped set up and is vice-chair of the committee for the British Heart Foundation (BHF) ‘hope for hearts’ innovation fund (up to £1 million to help support innovation to help deliver better heart failure care).
In 2019 the UK’s largest heart failure patient charity, Pumping Marvellous Foundation, presented Paul with the Platinum patient educator award – recognising extraordinary work towards building awareness of heart failure and advocacy of better systems to improve care for patients.
He is committed to medical education and has helped organise regular national meetings (see www.bsh.org.uk and www.cardiorenalforum.com) for hospital doctors, GPs and specialist nurses. He actively contributes to education of cardiology trainees through roles with national (British Cardiovascular Society) and international (European Society for Cardiology) societies. This has included question writing and exam setting for the European Exam in General Cardiology for 10 years and in 2020 was appointed Chair of the UK standard setting group for this exam.
He has over 100 peer review publications and has edited a textbook ‘Specialist Training in Cardiology’ which was Highly Commended in the BMA Medical Book Competition.
Professor Pallav Shah covers bronchoscopy techniques and how these have evolved over time, providing insights into case studies.
This talk discusses lung disease and respiratory health related to pulmonary medicine, regarding the recent respiratory pandemic.
This talk provides insights into recent published work on the preliminary data on validation of critically ill COVID-19 patients.
This talk focuses on multi-disciplinary discussions around opportunistic targeted AF case findings, utilising innovative ECG technology and how digital transformation is set to change healthcare.
This talk provides insights into the crystal accumulation and mucus plugging as a driver of severe asthma of type 2 immunity.
Dr Rakesh Sharma provides an overview on the rising prevalence of cardiac sarcoidosis; how to diagnose and manage the disease.
This talk discusses the journeys through the different states of sleep and reality, whilst reviewing case studies.
This talk from the PCHF London graduation ceremony provides an overview of the achievements in cardiology and what the future holds.
This talk discusses integrating bedside ultrasound for the haemodynamic assessment and fluid status assessment in cardiothoracic patients, delving into the latest advances in the field of point of care ultrasound (POCUS).
This talk focuses on how to manage chronic kidney disease in primary care and where SGLT2 inhibitors fit in the management alongside RAASi therapy.
Professor Mervyn Singer provides an overview of sepsis, focusing on the strong impact the media has on the awareness of the condition.